Atara Biotherapeutics's total assets for Q1 2026 were $20.00M, a decrease of -1.18% from the previous quarter. ATRA total liabilities were $57.31M for the fiscal quarter, a -2.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.